Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Schelosky

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Acta Neurologica Scandinavica. Supplementum|January 1, 1993
Current strategies in the drug treatment of advanced Parkinson's disease--new modes of dopamine substitutionL Schelosky, W Poewe
Versicherungsmedizin|August 1, 1994
[Life expectancy and disability in Parkinson disease]L Schelosky, W Poewe
Behavioural Neurology|February 4, 2014
Lack of selective vulnerability to anticholinergic induced cognitive impairment in early Parkinson's diseaseL Schelosky, T Benke, W Poewe
Journal of Neural Transmission. Supplementum|January 1, 1991
Effects of treatment with trihexyphenidyl on cognitive function in early Parkinson's diseaseL Schelosky, T Benke, W H Poewe
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challengesA Schrag, L Schelosky, U Scholz, et al.
Annals of Neurology|June 1, 1991
High-speed memory scanning in Parkinson's disease: adverse effects of levodopaW Poewe, W Berger, T Benke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1995
Hemimasticatory spasm in hemifacial atrophy: diagnostic and therapeutic aspects in two patientsG Ebersbach, C Kabus, L Schelosky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 1997
Quantitative assessment of botulinum toxin treatment in 43 patients with head tremorJ Wissel, F Masuhr, L Schelosky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Dystonia in ataxia telangiectasia: report of a case with putaminal lesions and decreased striatal [123I]iodobenzamide bindingM Koepp, L Schelosky, I Cordes, et al.
Neuropsychologia|July 1, 1994
Perseverative motor behaviour in Parkinson's diseaseG Ebersbach, H Hättig, L Schelosky, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Acta Neurologica Scandinavica. Supplementum|January 1, 1993
Current strategies in the drug treatment of advanced Parkinson's disease--new modes of dopamine substitutionL Schelosky, W Poewe
Versicherungsmedizin|August 1, 1994
[Life expectancy and disability in Parkinson disease]L Schelosky, W Poewe
Behavioural Neurology|February 4, 2014
Lack of selective vulnerability to anticholinergic induced cognitive impairment in early Parkinson's diseaseL Schelosky, T Benke, W Poewe
Journal of Neural Transmission. Supplementum|January 1, 1991
Effects of treatment with trihexyphenidyl on cognitive function in early Parkinson's diseaseL Schelosky, T Benke, W H Poewe
Movement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challengesA Schrag, L Schelosky, U Scholz, et al.
Annals of Neurology|June 1, 1991
High-speed memory scanning in Parkinson's disease: adverse effects of levodopaW Poewe, W Berger, T Benke, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1995
Hemimasticatory spasm in hemifacial atrophy: diagnostic and therapeutic aspects in two patientsG Ebersbach, C Kabus, L Schelosky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 26, 1997
Quantitative assessment of botulinum toxin treatment in 43 patients with head tremorJ Wissel, F Masuhr, L Schelosky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Dystonia in ataxia telangiectasia: report of a case with putaminal lesions and decreased striatal [123I]iodobenzamide bindingM Koepp, L Schelosky, I Cordes, et al.
Neuropsychologia|July 1, 1994
Perseverative motor behaviour in Parkinson's diseaseG Ebersbach, H Hättig, L Schelosky, et al.
Pageof 3